| Hester Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524669 |
NSE Symbol : HESTERBIO |
P/E(TTM) : 63.66 |
|
ISIN Demat : INE782E01017 |
Div & Yield% : 0.25 |
EPS(TTM) : 37.23 |
|
Book Value(₹) : 382.47 |
Market Cap(₹Cr) : 2,016.25 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 73.50 | 73.47 | 72.87 | 65.51 | 66.43 | 80.35 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 73.50 | 73.47 | 72.87 | 65.51 | 66.43 | 80.35 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.35 | 1.06 | 1.20 | 0.98 | 1.22 | 0.86 |
| Total Income | 74.85 | 74.52 | 74.08 | 66.49 | 67.65 | 81.20 |
| Total Expenditure | 58.77 | 59.97 | 60.46 | 53.94 | 54.44 | 68.98 |
| PBIDT | 16.08 | 14.55 | 13.62 | 12.55 | 13.21 | 12.22 |
| Interest | 1.40 | 1.13 | 1.31 | 1.37 | 1.48 | 0.94 |
| PBDT | 14.68 | 13.43 | 12.31 | 11.18 | 11.74 | 11.28 |
| Depreciation | 2.19 | 2.12 | 2.08 | 2.57 | 2.58 | 2.55 |
| Tax | 3.07 | 2.87 | 3.28 | 1.51 | 2.48 | 2.37 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.08 | 0.00 | -0.48 | 0.63 | -0.11 | -0.10 |
| Reported Profit After Tax | 9.34 | 8.43 | 7.43 | 6.48 | 6.78 | 6.47 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 9.34 | 8.43 | 7.43 | 6.48 | 6.78 | 6.47 |
| EPS (Unit Curr.) | 10.97 | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 |
| EPS (Adj) (Unit Curr.) | 10.97 | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 |
| Calculated EPS (Unit Curr.) | 10.97 | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 |
| Calculated EPS (Adj) (Unit Curr.) | 10.97 | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 |
| Calculated EPS (Ann.) (Unit Curr.) | 43.90 | 39.65 | 34.94 | 30.45 | 31.89 | 30.43 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 43.90 | 39.65 | 34.94 | 30.45 | 31.89 | 30.43 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.88 | 19.80 | 18.69 | 19.16 | 19.89 | 15.21 |
| PBDTM(%) | 19.97 | 18.28 | 16.89 | 17.07 | 17.67 | 14.04 |
| PATM(%) | 12.71 | 11.47 | 10.20 | 9.89 | 10.21 | 8.05 |